IMMR Q3 2025 Earnings Strong EPS Beat Driven by Licensing and Royalty Revenue Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances DOCU Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear Block Inc XYZ Q1 2026 Earnings Strong EPS Beat of 2443 Surprises Markets Shares Dip Slightly AOMR Q1 2026 Earnings Mortgage REIT Misses Estimates Despite Positive Stock Response